Genomic landscape of cancer

Christopher J. Maher; Elaine R. Mardis

doi:10.1093/oso/9780190238667.003.0004

Genomic landscape of cancer

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

The study of cancer genomics has advanced rapidly during the last decade due to the development of next generation or massively parallel technology for DNA sequencing. The resulting knowledge is transforming the understanding of both inherited (germline) genetic susceptibility and the somatic changes in tumor tissue that drive abnormal growth and progression. The somatic alterations in tumor tissue vary depending on the type of cancer and its characteristic “genomic landscape.” New technologies have increased the speed and lowered the cost of DNA sequencing and have enabled high-volume characterization of RNA, DNA methylation, DNA-protein complexes, DNA conformation, and a host of other factors that, when altered, can contribute to the development and/or progression of the cancer. Technologic advances have greatly expanded research on somatic changes in tumor tissue, revealing both the singularity of individual cancer genomes and the commonality of genetic alterations that drive cancer in different tissues.

Original language	English
Title of host publication	Schottenfeld and Fraumeni Cancer Epidemiology and Prevention, Fourth Edition
Publisher	Oxford University Press
Pages	43-52
Number of pages	10
ISBN (Electronic)	9780190238667
DOIs	https://doi.org/10.1093/oso/9780190238667.003.0004
State	Published - Jan 1 2017

Keywords

Cancer
Cancer genomics
DNA
Genome
Next generation sequencing
Tumor

Access to Document

10.1093/oso/9780190238667.003.0004

Cite this

@inbook{70adb62ed79c4657b1700b8d4a9fe12c,

title = "Genomic landscape of cancer",

abstract = "The study of cancer genomics has advanced rapidly during the last decade due to the development of next generation or massively parallel technology for DNA sequencing. The resulting knowledge is transforming the understanding of both inherited (germline) genetic susceptibility and the somatic changes in tumor tissue that drive abnormal growth and progression. The somatic alterations in tumor tissue vary depending on the type of cancer and its characteristic “genomic landscape.” New technologies have increased the speed and lowered the cost of DNA sequencing and have enabled high-volume characterization of RNA, DNA methylation, DNA-protein complexes, DNA conformation, and a host of other factors that, when altered, can contribute to the development and/or progression of the cancer. Technologic advances have greatly expanded research on somatic changes in tumor tissue, revealing both the singularity of individual cancer genomes and the commonality of genetic alterations that drive cancer in different tissues.",

keywords = "Cancer, Cancer genomics, DNA, Genome, Next generation sequencing, Tumor",

author = "Maher, {Christopher J.} and Mardis, {Elaine R.}",

note = "Publisher Copyright: {\textcopyright} Oxford University Press 2018.",

year = "2017",

month = jan,

day = "1",

doi = "10.1093/oso/9780190238667.003.0004",

language = "English",

pages = "43--52",

booktitle = "Schottenfeld and Fraumeni Cancer Epidemiology and Prevention, Fourth Edition",

publisher = "Oxford University Press",

}

TY - CHAP

T1 - Genomic landscape of cancer

AU - Maher, Christopher J.

AU - Mardis, Elaine R.

N1 - Publisher Copyright: © Oxford University Press 2018.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The study of cancer genomics has advanced rapidly during the last decade due to the development of next generation or massively parallel technology for DNA sequencing. The resulting knowledge is transforming the understanding of both inherited (germline) genetic susceptibility and the somatic changes in tumor tissue that drive abnormal growth and progression. The somatic alterations in tumor tissue vary depending on the type of cancer and its characteristic “genomic landscape.” New technologies have increased the speed and lowered the cost of DNA sequencing and have enabled high-volume characterization of RNA, DNA methylation, DNA-protein complexes, DNA conformation, and a host of other factors that, when altered, can contribute to the development and/or progression of the cancer. Technologic advances have greatly expanded research on somatic changes in tumor tissue, revealing both the singularity of individual cancer genomes and the commonality of genetic alterations that drive cancer in different tissues.

AB - The study of cancer genomics has advanced rapidly during the last decade due to the development of next generation or massively parallel technology for DNA sequencing. The resulting knowledge is transforming the understanding of both inherited (germline) genetic susceptibility and the somatic changes in tumor tissue that drive abnormal growth and progression. The somatic alterations in tumor tissue vary depending on the type of cancer and its characteristic “genomic landscape.” New technologies have increased the speed and lowered the cost of DNA sequencing and have enabled high-volume characterization of RNA, DNA methylation, DNA-protein complexes, DNA conformation, and a host of other factors that, when altered, can contribute to the development and/or progression of the cancer. Technologic advances have greatly expanded research on somatic changes in tumor tissue, revealing both the singularity of individual cancer genomes and the commonality of genetic alterations that drive cancer in different tissues.

KW - Cancer

KW - Cancer genomics

KW - DNA

KW - Genome

KW - Next generation sequencing

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=85051052151&partnerID=8YFLogxK

U2 - 10.1093/oso/9780190238667.003.0004

DO - 10.1093/oso/9780190238667.003.0004

M3 - Chapter

AN - SCOPUS:85051052151

SP - 43

EP - 52

BT - Schottenfeld and Fraumeni Cancer Epidemiology and Prevention, Fourth Edition

PB - Oxford University Press

ER -

Genomic landscape of cancer

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this